1. Home
  2. LYRA vs PMNT Comparison

LYRA vs PMNT Comparison

Compare LYRA & PMNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • PMNT
  • Stock Information
  • Founded
  • LYRA 2005
  • PMNT 1984
  • Country
  • LYRA United States
  • PMNT United Kingdom
  • Employees
  • LYRA N/A
  • PMNT N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • PMNT
  • Sector
  • LYRA Health Care
  • PMNT
  • Exchange
  • LYRA Nasdaq
  • PMNT NYSE
  • Market Cap
  • LYRA 11.8M
  • PMNT 11.2M
  • IPO Year
  • LYRA 2020
  • PMNT 2024
  • Fundamental
  • Price
  • LYRA $0.12
  • PMNT $1.15
  • Analyst Decision
  • LYRA Hold
  • PMNT Strong Buy
  • Analyst Count
  • LYRA 4
  • PMNT 1
  • Target Price
  • LYRA $1.25
  • PMNT $6.00
  • AVG Volume (30 Days)
  • LYRA 828.8K
  • PMNT 91.0K
  • Earning Date
  • LYRA 03-13-2025
  • PMNT 02-14-2025
  • Dividend Yield
  • LYRA N/A
  • PMNT N/A
  • EPS Growth
  • LYRA N/A
  • PMNT N/A
  • EPS
  • LYRA N/A
  • PMNT N/A
  • Revenue
  • LYRA $1,534,000.00
  • PMNT $21,307,000.00
  • Revenue This Year
  • LYRA N/A
  • PMNT $3.91
  • Revenue Next Year
  • LYRA $519.89
  • PMNT $29.32
  • P/E Ratio
  • LYRA N/A
  • PMNT N/A
  • Revenue Growth
  • LYRA N/A
  • PMNT N/A
  • 52 Week Low
  • LYRA $0.12
  • PMNT $0.66
  • 52 Week High
  • LYRA $6.29
  • PMNT $3.55
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 23.27
  • PMNT N/A
  • Support Level
  • LYRA $0.14
  • PMNT N/A
  • Resistance Level
  • LYRA $0.20
  • PMNT N/A
  • Average True Range (ATR)
  • LYRA 0.01
  • PMNT 0.00
  • MACD
  • LYRA -0.00
  • PMNT 0.00
  • Stochastic Oscillator
  • LYRA 1.05
  • PMNT 0.00

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About PMNT PERFECT MOMENT LTD

Perfect Moment Ltd is a company which is a luxury lifestyle brand that combines fashion and technical performance for its ranges of skiwear, outerwear, swimwear, and activewear. It operates at the intersection of luxury fashion and multi-channel commerce. Although the Company is organized fundamentally as one business segment which is product sales, the Company's revenues are primarily split between three geographic areas which are the U. S., Europe, and the UK.

Share on Social Networks: